Breakthroughs in Deuterated Drug R&D with Alfa Chemistry’s Building Blocks & Intermediates
New York, United States, August 27, 2025 — Alfa Chemistry, a global Contract Research Organization (CRO) specializing in organic, material, and medicinal chemistry, has announced that it is adding more high-purity deuterated building blocks and… Read More »Breakthroughs in Deuterated Drug R&D with Alfa Chemistry’s Building Blocks & Intermediates





